Medicare Enrolled

Dr. Ann Navar, MD, PHD

Cardiovascular Disease · Dallas, TX
6201 HARRY HINES BLVD, Dallas, TX 75390
2146457501
Registered in NPPES since 2009
NPI: 1609018639 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Navar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Navar? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Navar

Dr. Ann Navar is a cardiovascular disease specialist in Dallas, TX, with 17 years of NPI registration.

Between the years covered by Open Payments, Dr. Navar received a total of $598,925 from 25 pharmaceutical and/or device companies across 316 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Navar is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years of NPI registration $598,925 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$598,925
Total received (2018-2024)
Avg $85,561/year across 7 years
Top 1% in TX for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
25
Companies
316
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$152,296
2023
$79,266
2022
$67,542
2021
$46,770
2020
$77,695
2019
$84,858
2018
$90,499

Payments by company (2024)

Eli Lilly and Company
$115,138
Merck Sharp & Dohme LLC
$14,307
Amgen Inc.
$8,253
Novartis Pharmaceuticals Corporation
$6,300
Genentech, Inc.
$5,972
Novo Nordisk AS
$2,325
Top 3 companies account for 90.4% of 2024 payments
All-time payments by company (2018-2024) ›
Eli Lilly and Company
$152,354
Novo Nordisk AS
$82,763
SANOFI-AVENTIS U.S. LLC
$69,780
Amarin Pharma Inc.
$61,024
Novo Nordisk Inc
$48,678
Amgen Inc.
$29,852
Regeneron Pharmaceuticals, Inc.
$20,049
Merck Sharp & Dohme LLC
$19,802
Novartis Pharmaceuticals Corporation
$17,474
AstraZeneca Pharmaceuticals LP
$17,384
Bayer HealthCare Pharmaceuticals Inc.
$15,850
Janssen Scientific Affairs, LLC
$13,156
Bayer Healthcare Pharmaceuticals Inc.
$13,058
PFIZER INC.
$9,750
NOVARTIS PHARMACEUTICALS CORPORATION
$9,162
E.R. Squibb & Sons, L.L.C.
$7,479
Genentech, Inc.
$5,972
Boehringer Ingelheim International GmbH
$1,740
CSL Behring
$1,635
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,600
Janssen Pharmaceuticals, Inc
$132
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$100
BOSTON SCIENTIFIC CORPORATION
$98
Esperion Therapeutics, Inc.
$21
AQUESTIVE THERAPEUTICS, INC.
$13
Top 3 companies account for 50.9% of all-time payments
Associated products mentioned in payments ›
BRILINTA · ELIQUIS · EPANOVA · EVENITY · GENERAL PAIN MANAGEMENT · HYPERLIPIDEMIA - DISEASE · JARDIANCE · Kerendia · LEQVIO · LifeVest · NEXLETOL · NO PRODUCT DISCUSSED · Non-Covered · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Repatha · SYMPAZAN · Vascepa · Victoza · XARELTO
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a cardiovascular disease specialist in Dallas?
Compare cardiologists in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse cardiologists nearby

Geographic Context

Cardiologists in nearby ZIP areas
304
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
UT OF TEXAS SOUTHWESTERN UNIVERSITY HOSPITAL - WILLIAM P. CLEMENTS JR.
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Navar is a cardiovascular disease specialist, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Navar receive payments from pharmaceutical companies?
Yes. Dr. Navar received a total of $598,925 from 25 companies across 316 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Navar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Cardiologists in Dallas
Browse cardiologists in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in TX
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in TX
Which TX cardiologists receive the most from drug and device companies.
By company
Eli Lilly and Company Payments to Doctors
See all physicians who received payments from Eli Lilly and Company.
By company
Novo Nordisk AS Payments to Doctors
See all physicians who received payments from Novo Nordisk AS.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →